Applies statistics and data science in clinical pharmacology and epidemiology to evaluate diagnostics, outcomes, and safety. Focus includes opioid use disorder therapies, pain therapeutics, patient‑reported outcomes, medical devices, and health equity, integrating pharmacogenetics and psychopharmacology.